You are the technical supervisor of the blood bank. One of…
You are the technical supervisor of the blood bank. One of your techs suggests that it would be more cost effective to perform antibody screening on patients using commercially available pooled reagent red blood cells rather than a three-cell screen. The tech reasons that the pooled reagent requires only one gel well for testing versus three wells for the typical screen cells. This would mean cost savings! Is it acceptable to use pooled screening cells for patient pre-transfusion testing? Why or why not?
Read Details